Annual Interest Expense
$289.44 M
+$1.20 M+0.41%
31 December 2023
Summary:
Jazz Pharmaceuticals annual interest expense is currently $289.44 million, with the most recent change of +$1.20 million (+0.41%) on 31 December 2023. During the last 3 years, it has risen by +$10.67 million (+3.83%). JAZZ annual interest expense is now at all-time high.JAZZ Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$58.70 M
-$3.32 M-5.35%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly interest expense is currently $58.70 million, with the most recent change of -$3.32 million (-5.35%) on 30 September 2024. Over the past year, it has dropped by -$11.62 million (-16.53%). JAZZ quarterly interest expense is now -37.13% below its all-time high of $93.37 million, reached on 30 September 2021.JAZZ Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$257.17 M
-$12.79 M-4.74%
30 September 2024
Summary:
Jazz Pharmaceuticals TTM interest expense is currently $257.17 million, with the most recent change of -$12.79 million (-4.74%) on 30 September 2024. Over the past year, it has dropped by -$32.27 million (-11.15%). JAZZ TTM interest expense is now -20.15% below its all-time high of $322.07 million, reached on 31 March 2022.JAZZ TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -16.5% | -11.2% |
| 3 y3 years | +3.8% | -33.7% | -7.8% |
| 5 y5 years | +300.6% | +221.8% | +255.9% |
JAZZ Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3.8% | -33.7% | at low | -20.1% | at low |
| 5 y | 5 years | at high | +300.6% | -37.1% | +221.8% | -20.1% | +255.9% |
| alltime | all time | at high | >+9999.0% | -37.1% | >+9999.0% | -20.1% | >+9999.0% |
Jazz Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $58.70 M(-5.4%) | $257.17 M(-4.7%) |
| June 2024 | - | $62.02 M(-6.2%) | $269.96 M(-4.1%) |
| Mar 2024 | - | $66.12 M(-6.0%) | $281.41 M(-2.8%) |
| Dec 2023 | $289.44 M(+0.4%) | $70.32 M(-1.6%) | $289.44 M(-1.3%) |
| Sept 2023 | - | $71.50 M(-2.7%) | $293.24 M(-2.9%) |
| June 2023 | - | $73.47 M(-0.9%) | $301.99 M(+3.5%) |
| Mar 2023 | - | $74.15 M(+0.0%) | $291.70 M(+1.2%) |
| Dec 2022 | $288.24 M(+3.4%) | $74.13 M(-7.6%) | $288.24 M(-4.8%) |
| Sept 2022 | - | $80.24 M(+27.0%) | $302.71 M(-4.2%) |
| June 2022 | - | $63.19 M(-10.6%) | $315.84 M(-1.9%) |
| Mar 2022 | - | $70.68 M(-20.2%) | $322.07 M(+15.5%) |
| Dec 2021 | $278.77 M(+179.6%) | $88.60 M(-5.1%) | $278.77 M(+28.0%) |
| Sept 2021 | - | $93.37 M(+34.5%) | $217.74 M(+43.4%) |
| June 2021 | - | $69.42 M(+153.6%) | $151.80 M(+39.8%) |
| Mar 2021 | - | $27.38 M(-0.7%) | $108.59 M(+8.9%) |
| Dec 2020 | $99.71 M(+38.0%) | $27.57 M(+0.5%) | $99.71 M(+10.3%) |
| Sept 2020 | - | $27.43 M(+4.6%) | $90.38 M(+11.8%) |
| June 2020 | - | $26.21 M(+41.7%) | $80.81 M(+11.0%) |
| Mar 2020 | - | $18.50 M(+1.4%) | $72.83 M(+0.8%) |
| Dec 2019 | $72.26 M(-7.9%) | $18.24 M(+2.1%) | $72.26 M(-1.5%) |
| Sept 2019 | - | $17.86 M(-2.0%) | $73.35 M(-1.4%) |
| June 2019 | - | $18.23 M(+1.7%) | $74.41 M(-1.9%) |
| Mar 2019 | - | $17.92 M(-7.3%) | $75.82 M(-3.4%) |
| Dec 2018 | $78.50 M(+1.0%) | $19.33 M(+2.2%) | $78.50 M(-2.6%) |
| Sept 2018 | - | $18.92 M(-3.7%) | $80.60 M(-0.3%) |
| June 2018 | - | $19.65 M(-4.7%) | $80.87 M(+1.7%) |
| Mar 2018 | - | $20.61 M(-3.8%) | $79.52 M(+2.3%) |
| Dec 2017 | $77.76 M(+25.5%) | $21.43 M(+11.6%) | $77.76 M(+3.0%) |
| Sept 2017 | - | $19.19 M(+4.9%) | $75.46 M(+0.9%) |
| June 2017 | - | $18.29 M(-2.9%) | $74.77 M(+9.0%) |
| Mar 2017 | - | $18.84 M(-1.5%) | $68.59 M(+10.7%) |
| Dec 2016 | $61.94 M | $19.13 M(+3.4%) | $61.94 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $18.50 M(+52.6%) | $55.02 M(+11.9%) |
| June 2016 | - | $12.12 M(-0.6%) | $49.17 M(-7.0%) |
| Mar 2016 | - | $12.19 M(-0.1%) | $52.86 M(-7.1%) |
| Dec 2015 | $56.92 M(+8.0%) | $12.21 M(-3.5%) | $56.92 M(-7.3%) |
| Sept 2015 | - | $12.65 M(-20.0%) | $61.38 M(-3.0%) |
| June 2015 | - | $15.81 M(-2.7%) | $63.27 M(+7.4%) |
| Mar 2015 | - | $16.25 M(-2.6%) | $58.88 M(+11.7%) |
| Dec 2014 | $52.71 M(+95.8%) | $16.68 M(+14.8%) | $52.71 M(+24.9%) |
| Sept 2014 | - | $14.53 M(+27.1%) | $42.21 M(+24.6%) |
| June 2014 | - | $11.43 M(+13.4%) | $33.88 M(+14.5%) |
| Mar 2014 | - | $10.08 M(+63.2%) | $29.59 M(+9.9%) |
| Dec 2013 | $26.92 M(+59.6%) | $6.17 M(-0.5%) | $26.92 M(-5.3%) |
| Sept 2013 | - | $6.20 M(-13.2%) | $28.41 M(-5.2%) |
| June 2013 | - | $7.14 M(-3.5%) | $29.96 M(+23.3%) |
| Mar 2013 | - | $7.40 M(-3.5%) | $24.30 M(+43.9%) |
| Dec 2012 | $16.87 M(+954.3%) | $7.67 M(-1.0%) | $16.89 M(+82.4%) |
| Sept 2012 | - | $7.75 M(+423.3%) | $9.26 M(+466.6%) |
| June 2012 | - | $1.48 M(<-9900.0%) | $1.63 M(+101.7%) |
| Mar 2012 | - | -$13.00 K(-131.7%) | $810.00 K(-49.4%) |
| Dec 2011 | $1.60 M(-87.4%) | $41.00 K(-67.2%) | $1.60 M(-39.2%) |
| Sept 2011 | - | $125.00 K(-81.0%) | $2.63 M(-29.0%) |
| June 2011 | - | $657.00 K(-15.4%) | $3.71 M(-52.1%) |
| Mar 2011 | - | $777.00 K(-27.6%) | $7.74 M(-39.2%) |
| Dec 2010 | $12.72 M(-44.2%) | $1.07 M(-10.6%) | $12.73 M(-26.9%) |
| Sept 2010 | - | $1.20 M(-74.4%) | $17.42 M(-19.4%) |
| June 2010 | - | $4.69 M(-18.7%) | $21.60 M(-5.1%) |
| Mar 2010 | - | $5.77 M(+0.1%) | $22.77 M(-0.1%) |
| Dec 2009 | $22.80 M(+15.5%) | $5.76 M(+7.0%) | $22.80 M(+33.8%) |
| Sept 2009 | - | $5.38 M(-8.1%) | $17.03 M(+46.2%) |
| June 2009 | - | $5.86 M(+1.1%) | $11.65 M(+101.1%) |
| Mar 2009 | - | $5.79 M | $5.79 M |
| Dec 2008 | $19.74 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly interest expense year-on-year change?
- What is Jazz Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM interest expense year-on-year change?
What is Jazz Pharmaceuticals annual interest expense?
The current annual interest expense of JAZZ is $289.44 M
What is the all time high annual interest expense for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual interest expense is $289.44 M
What is Jazz Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of JAZZ is $58.70 M
What is the all time high quarterly interest expense for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly interest expense is $93.37 M
What is Jazz Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, JAZZ quarterly interest expense has changed by -$11.62 M (-16.53%)
What is Jazz Pharmaceuticals TTM interest expense?
The current TTM interest expense of JAZZ is $257.17 M
What is the all time high TTM interest expense for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM interest expense is $322.07 M
What is Jazz Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, JAZZ TTM interest expense has changed by -$32.27 M (-11.15%)